» Articles » PMID: 35557947

Adapting Physiology in Functional Human Islet Organogenesis

Overview
Specialty Cell Biology
Date 2022 May 13
PMID 35557947
Authors
Affiliations
Soon will be listed here.
Abstract

Generation of three-dimensional (3D)-structured functional human islets is expected to be an alternative cell source for cadaveric human islet transplantation for the treatment of insulin-dependent diabetes. Human pluripotent stem cells (hPSCs), such as human embryonic stem cells (hESCs) and human induced pluripotent stem cells (hiPSCs), offer infinite resources for newly synthesized human islets. Recent advancements in hPSCs technology have enabled direct differentiation to human islet-like clusters, which can sense glucose and secrete insulin, and those islet clusters can ameliorate diabetes when transplanted into rodents or non-human primates (NHPs). However, the generated hPSC-derived human islet-like clusters are functionally immature compared with primary human islets. There remains a challenge to establish a technology to create fully functional human islets , which are functionally and transcriptionally indistinguishable from cadaveric human islets. Understanding the complex differentiation and maturation pathway is necessary to generate fully functional human islets for a tremendous supply of high-quality human islets with less batch-to-batch difference for millions of patients. In this review, I summarized the current progress in the generation of 3D-structured human islets from pluripotent stem cells and discussed the importance of adapting physiology for functional human islet organogenesis and possible improvements with environmental cues.

Citing Articles

Insulin-producing cells derived from expandable stem cell-derived endoderm are effective for the treatment of type 2 diabetes.

Yoshihara E Ann Transl Med. 2025; 12(6):121.

PMID: 39817230 PMC: 11729811. DOI: 10.21037/atm-24-129.


Scaling Insulin-Producing Cells by Multiple Strategies.

Choi J, Cayabyab F, Perez H, Yoshihara E Endocrinol Metab (Seoul). 2024; 39(2):191-205.

PMID: 38572534 PMC: 11066437. DOI: 10.3803/EnM.2023.1910.


A guide from the stomach to β cells.

Choi J, Cayabyab F, Yoshihara E Nat Cell Biol. 2023; 25(5):637-638.

PMID: 37106061 DOI: 10.1038/s41556-023-01140-w.


Overcoming the Limitations of Stem Cell-Derived Beta Cells.

Karimova M, Gvazava I, Vorotelyak E Biomolecules. 2022; 12(6).

PMID: 35740935 PMC: 9221417. DOI: 10.3390/biom12060810.

References
1.
Picard F, Wanatabe M, Schoonjans K, Lydon J, OMalley B, Auwerx J . Progesterone receptor knockout mice have an improved glucose homeostasis secondary to beta -cell proliferation. Proc Natl Acad Sci U S A. 2002; 99(24):15644-8. PMC: 137770. DOI: 10.1073/pnas.202612199. View

2.
Fan W, He N, Lin C, Wei Z, Hah N, Waizenegger W . ERRγ Promotes Angiogenesis, Mitochondrial Biogenesis, and Oxidative Remodeling in PGC1α/β-Deficient Muscle. Cell Rep. 2018; 22(10):2521-2529. PMC: 5860878. DOI: 10.1016/j.celrep.2018.02.047. View

3.
Marcheva B, Ramsey K, Buhr E, Kobayashi Y, Su H, Ko C . Disruption of the clock components CLOCK and BMAL1 leads to hypoinsulinaemia and diabetes. Nature. 2010; 466(7306):627-31. PMC: 2920067. DOI: 10.1038/nature09253. View

4.
Kadison A, Kim J, Maldonado T, Crisera C, Prasadan K, Manna P . Retinoid signaling directs secondary lineage selection in pancreatic organogenesis. J Pediatr Surg. 2001; 36(8):1150-6. DOI: 10.1053/jpsu.2001.25734. View

5.
Prentice K, Saksi J, Robertson L, Lee G, Inouye K, Eguchi K . A hormone complex of FABP4 and nucleoside kinases regulates islet function. Nature. 2021; 600(7890):720-726. PMC: 8983123. DOI: 10.1038/s41586-021-04137-3. View